Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China

Abstract EN

We investigated the clinical epidemiology of mineral bone disorder markers in prevalent hemodialysis (HD) patients in Xinjiang, the largest province in China.

Data were obtained from 59 hospitals.

A total of 3725 patients tracked from January 1 to December 31, 2014, were enrolled.

Serum calcium (Ca) levels, phosphorus (P) levels, and intact parathyroid hormone (iPTH) levels were analyzed.

Serum Ca levels were lower compared to the International Dialysis Outcomes and Practice Patterns Study (DOPPS4) and the Chinese DOPPS.

The hypercalcemia rate was similar to DOPPS4 and lower than in the Chinese DOPPS.

Serum P levels were higher than in DOPPS4 and lower than those in the Chinese DOPPS.

Hyperphosphatemia rates were higher than DOPPS4 and lower than Chinese DOPPS.

Serum iPTH levels were higher than in DOPPS4 and the Chinese DOPPS.

We demonstrated higher serum P and iPTH levels in Xinjiang HD patients than in the DOPPS4 and Chinese DOPPS.

In contrast, serum Ca levels were lower than the other two studies.

High hypocalcemia and hyperphosphatemia rates may suggest that HD services in Xinjiang are inadequate.

A multidiscipline chronic kidney disease (CKD) care program needs to be established to improve chronic kidney disease-mineral and bone disorder (CKD-MBD) target achievement in Xinjiang.